Down-regulation of surface monocyte lipopolysaccharide-receptor cd14 in patients on cardiopulmonary bypass undergoing aorta-coronary bypass operation
- 31 May 1998
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 115 (5) , 1172-1178
- https://doi.org/10.1016/s0022-5223(98)70418-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- CYTOKINE PRODUCTION PRECEDES THE EXPANSION OF CD14+CD16+ MONOCYTES IN HUMAN SEPSISShock, 1997
- Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulationImmunology Today, 1996
- Increased Serum Concentration of Soluble CD14 Is a Prognostic Marker in Gram-Positive SepsisClinical Immunology and Immunopathology, 1996
- Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1995
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- Alterations of cell-mediated immune response following cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery, 1993
- Lipopolysaccharide induces up‐regulation of CD14 molecule on monocytes in human whole bloodEuropean Journal of Immunology, 1992
- Influence of 4 different membrane oxygenators on inflammation-like processes during extracorporeal circulation with pulsatile and non-pulsatile flowEuropean Journal of Cardio-Thoracic Surgery, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypassScandinavian Journal of Thoracic and Cardiovascular Surgery, 1987